MEG Q1 Earnings Call: Organic Growth, Regulatory Tailwinds, and Margin Expansion Drive Results

MEG Cover Image

Environmental services provider Montrose (NYSE: MEG) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 14.5% year on year to $177.8 million. The company’s full-year revenue guidance of $760 million at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $0.07 per share was significantly above analysts’ consensus estimates.

Is now the time to buy MEG? Find out in our full research report (it’s free).

Montrose (MEG) Q1 CY2025 Highlights:

  • Revenue: $177.8 million vs analyst estimates of $167.8 million (14.5% year-on-year growth, 6% beat)
  • Adjusted EPS: $0.07 vs analyst estimates of -$0.09 (significant beat)
  • The company reconfirmed its revenue guidance for the full year of $760 million at the midpoint
  • EBITDA guidance for the full year is $106.5 million at the midpoint, above analyst estimates of $104.5 million
  • Operating Margin: -5.9%, in line with the same quarter last year
  • Organic Revenue rose 6.6% year on year (1.1% in the same quarter last year)
  • Market Capitalization: $776.7 million

StockStory’s Take

Montrose’s first quarter performance was shaped by broad-based demand for environmental services across its core segments, with leadership emphasizing organic revenue gains and momentum in high-growth areas. CEO Vijay Manthripragada highlighted that the Measurement and Analysis and Remediation and Reuse segments each contributed to the company’s expansion, citing cross-selling efforts and successful execution on large client projects. Management noted that clients, particularly in the private sector, are maintaining their commitment to compliance and sustainability goals despite regulatory and political uncertainty. CFO Allan Dicks further pointed to operational efficiencies and normalization of segment margins as factors supporting higher adjusted EBITDA, reflecting a consistent focus on both top-line growth and profitability.

Looking ahead, Montrose’s outlook is anchored by expectations of continued organic growth, margin improvement, and resilience against regulatory volatility. Manthripragada stated that emerging state-level environmental policies and ongoing federal activity around PFAS (per- and polyfluoroalkyl substances) regulation are expected to fuel demand, while the company’s proprietary PFAS treatment technology positions it well for future projects. Management also pointed to limited exposure to federal spending and minimal anticipated impact from tariffs or macroeconomic shifts, reinforcing confidence in the company’s guidance. As Manthripragada explained, “We are well on track for high single-digit organic revenue growth, and we continue to enhance EBITDA margins, which is evident from our raised EBITDA guidance.”

Key Insights from Management’s Remarks

Montrose’s leadership attributed the quarter’s performance to increased demand in key service areas, client stability amid regulatory changes, and strategic execution on cross-segment opportunities.

  • Measurement and Analysis strength: The Measurement and Analysis segment saw robust demand across both laboratory and field services, with management crediting sustained client requirements for compliance and risk mitigation. Manthripragada explained that broad-based demand, rather than a single driver, propelled the segment’s performance, and higher-margin business lines contributed to improved segment profitability.

  • PFAS-related services growth: The company recorded its fifth consecutive quarter of growth in PFAS (per- and polyfluoroalkyl substances) services, which are used to address emerging contaminants in water, air, and soil. Management cited recent federal policy actions as reinforcing long-term demand, and noted that Montrose’s proprietary treatment solutions can be adapted to evolving regulatory thresholds.

  • Remediation and Reuse momentum: Revenue in the Remediation and Reuse segment increased, benefiting from organic growth in treatment technologies and support from recent acquisitions. CFO Allan Dicks highlighted that margins in this segment are expected to improve throughout the year as business mix and project timing normalize.

  • Segment margin normalization: Management reported that segment margins are converging toward stated long-term targets through process optimization, automation, and leveraging existing infrastructure. These efforts have contributed to improved operating efficiency and are expected to drive further margin expansion in 2025.

  • Minimal tariff and macroeconomic impact: The company does not expect tariffs or broader macroeconomic conditions to meaningfully affect margins or demand, given the essential nature of its services and the long-term planning cycles of its primarily private sector clients. Montrose’s exposure to federal spending is limited, further reducing risk from potential regulatory or budgetary shifts.

Drivers of Future Performance

Montrose’s forward outlook is underpinned by consistent demand for environmental compliance solutions, state and federal regulatory developments, and ongoing operational improvements.

  • State-level regulatory drivers: Management believes that increasing influence and activity by U.S. state governments in environmental policy will create new opportunities, particularly for PFAS remediation and water contamination projects. States are expected to play a larger role in setting and enforcing standards, supporting recurring demand for Montrose’s services.

  • Margin expansion initiatives: The company is pursuing margin improvement through process automation, operating leverage, and aligning segment-level profitability with long-term targets. The Remediation and Reuse and Measurement and Analysis segments are expected to be the primary contributors to adjusted EBITDA margin gains in 2025.

  • Capital allocation and balance sheet priorities: After completing the redemption of preferred stock, management expects leverage to remain below its long-term target and is prepared to resume strategic M&A when conditions are right. The new stock repurchase program is positioned as an additional tool for shareholder returns, but growth investments and balance sheet optimization remain priorities.

Catalysts in Upcoming Quarters

In the coming quarters, our team will be monitoring (1) the pace of state-level regulatory developments, especially regarding PFAS standards and remediation projects; (2) progress on operating margin expansion in the Remediation and Reuse and Measurement and Analysis segments; and (3) execution of the capital allocation strategy, including the completion of preferred stock redemptions and balance sheet simplification. Performance in these areas will be key indicators of sustained growth and profitability.

Montrose currently trades at a forward EV-to-EBITDA ratio of 8.9×. In the wake of earnings, is it a buy or sell? Find out in our full research report (it’s free).

Stocks That Trumped Tariffs

The market surged in 2024 and reached record highs after Donald Trump’s presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.

While the crowd speculates what might happen next, we’re homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver’s seat and build a durable portfolio by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.